Partner With Us NRI

Krishna Institute of Medical Sciences Ltd share Price Today

Company details

6M Return 4.04%
1Y Return 18.84%
Mkt Cap.(Cr) 16,444.15
Volume 26,886
Div Yield 0.00%
OI Chg %
Volume 26,886

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Healthcare Facilities company Krishna Institute of Medical Sciences announced Q4FY24 & FY24 results:

  • Gross revenue at Rs 6376 million, an increase of 9.8% on YoY and 4.7% on QoQ basis.
  • EBITDA of Rs 1628 million, a decline of 3.2% on YoY and growth by 8.3% on QoQ basis.
  • EBITDA margin in Q4FY24 stood at 25.5% vs. 28.9% in Q4 FY23 and 24.7% in Q3 FY24.
  • EBITDA (excluding Other Income) Margin stands at 25.1%, showing a decline of 3.2% on YoY and an increase of 0.8% on QoQ.
  • PAT at Rs 716 million in Q4FY24 against Rs 987 million and Rs 767 million in Q4 FY23 and Q3 FY24 respectively.
  • Consolidated EPS declined by 29.8% on YoY and 8.8% on QoQ basis to Rs 8
  • Bed occupancy in Q4FY24 at 51.4%*, a decline by 1.7% on YoY and 2.8% QoQ basis. [*As per the industry standard, % occupancy is mentioned as % to bed capacity, rather than % to census beds, from this quarter]
  • Cash and Cash Equivalents at Rs 132 crore as at 31st March, 2024. Net Debt to Equity ratio at 0.44

Announcing Q4 results, Dr. B Bhaskar Rao, CMD, KIMS Hospitals, said: Over all FY 24 has been a clinically and financially a good year for us. I am particularly pleased that our newly acquired units of Sunshine and Nagpur have shown good momentum. I am confident that FY25 will see robust growth with our new unit coming up at Nashik in Q1FY25 & Thane and Bangalore units getting operationalized by the end of FY25”

Result PDF

View Other Company Results

Krishna Institute of Medical Sciences Ltd shares SWOT Analysis

Strengths (4)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Book Value per share Improving for last 2 years

Weakness (5)

  • MFs decreased their shareholding last quarter
  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years

Opportunity (1)

  • RSI indicating price strength

Threats (3)

  • High PE (PE > 40)
  • Companies Increasing Debt as per Annual Report
  • Increasing Trend in Non-Core Income

Resistance and support

R1 2,073.5
R2 2,092.1
R3 2,113.0


S1 2,034.0
S2 2,013.1
S3 1,994.5
Delivery and volume
SBI LIFE INSURANCE COMPANY LTD Bulk Purchase 2024-02-06 2085 1149074 BSE
INDIA ADVANTAGE FUND S4-I Bulk Sell 2024-02-06 2085 1070545 BSE
SBI MUTUAL FUND Bulk Purchase 2023-06-20 1710 4068698 BSE
Name Category Shares
Bhaskara Rao Bollineni PROMOTER 26.27%
Bollineni Seenaiah Naidu PROMOTER 4.27%
Rajyasri Bollineni PROMOTER 1.72%
Bollineni Ramanaiah Memorial Hospitals Pvt Ltd PROMOTER 6.05%


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Krishna Institute of Medical Sciences Ltd Stocks COMPARISON

Financials( in Cr) Krishna Institute of Medical Sciences Ltd Apollo Hospitals Enterprise Ltd Max Healthcare Institute Ltd Fortis Healthcare Ltd Global Health Ltd
Price 2,054.80 6,259.55 897.85 485.00 1,310.20
% Change 0.03 1.45 -3.27 -0.75 -1.39
Mcap Cr 16,444.15 90,002.94 87,263.12 36,615.46 35,179.79
Revenue TTM Cr 2,197.68 16,612.50 4,831.37 6,537.06 2,694.25
Net Profit TTM Cr 365.81 887.50 1,103.51 632.98 326.08
PE TTM 53.02 100.27 82.56 62.38 73.55
1 Year Return 18.84 22.29 54.96 56.70 98.20
ROCE 25.90 14.16 13.85 7.51 16.49
ROE 23.93 15.04 16.12 6.79 16.13

Equity Capital: 1,669.54 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 34,603.75 11,365.18
LAST 3M 103,254.09 -13,985.70
LAST 6M 182,650.74 -3,739.19
LAST 12M 295,819.56 101,589.49

Krishna Institute of Medical Sciences Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • Krishna Institute of Medical Sciences Limited (KIMS) was incorporated as `Jagjit Singh and Sons Private Limited`, a Private Limited Company on July 26, 1973 in Mumbai. Subsequently, name of the Company was changed to `Krishna Institute of Medical Sciences Private Limited` on January 2, 2004. Pursuant to the conversion of Company to a Public Limited Company, the name was changed to `Krishna Institute of Medical Sciences Limited` on January 29, 2004. The Company is one of the largest corporate groups in India, with hospitals in Telangana, Andhra Pradesh & Maharashtra providing multi-disciplinary integrated services with a focus on tertiary and quaternary healthcare at affordable cost. It operate 12 multispecialty hospitals under the "KIMS Hospitals" brand, with an aggregate capacity of over 4,000 beds. It offer a comprehensive range of healthcare services in over 40 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother & child care. Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. In February 2003, acting in pursuance of the Takeover MoU, certain of its Promoters, namely Dr. Bhaskar Rao Bollineni, Krishnaiah Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company. Led by Dr. Bhaskar Rao Bollineni, Managing Director and CEO of the Company, a renowned cardiothoracic surgeon, it has grown from a single hospital to a chain of multispecialty hospitals, both organically and through strategic acquisitions. The oldest hospital in their network was established in 2000 at Nellore, by its Corporate Promoter, BRMH, with a capacity of approximately 200 beds and, At present, the hospital network has grown to six multispecialty hospitals in six cities, with a total capacity of 2,120 beds, including 1,705 operational beds. The Hospitals are equipped with state-of-the-art medical equipment and employ practices and policies which help to provide quality healthcare services to their patients. It was one of the first hospitals in Hyderabad to install 4-Arm HD da Vinci Robot technology at Secunderabad hospital. The flagship hospitals at Secunderabad and Rajahmundry have been accredited by the National Accreditation Board for Hospitals and Healthcare Providers, India ("NABH"). The Hospital at Secunderabad is accredited with ISO 9001:2008 certification and has also been accredited by the National Accreditation Board for Testing and Calibration Laboratories ("NABL"). The Hospital situated at Secunderabad was awarded the `Healthcare Excellence Award`, by the Indo Global Healthcare Summit and Expo, in 2015. It has also received awards from the Association of Healthcare Providers (India) ("AHPI") for nursing excellence, in 2015 and for `Patient Friendly Hospital`, in 2017. In 2017, it was awarded the best hospital of the year in the multispecialty hospital category in Hyderabad by Times Healthcare Achievers Awards and in 2016 received the Pharmacie DeQualite certification from Bureau Veritas. Further, it was the first hospital in Andhra Pradesh and Telangana to have been Green OT certified in 2016. It is also the laureate of the Asia Pacific Society of Infection Control CSSD Center of Excellence Silver Award 2015-2016. Neurology India Journal has ranked the neurology department at its hospital at Secunderabad as the third biggest centre in India on the basis of volume of epilepsy surgeries performed, as on July 31, 2016. In addition to healthcare services, the company also conduct medical education programmes through its affiliations with state medical boards and universities, for various broad and super specialties at its hospitals in Secunderabad and Rajahmundry, including for DNB, under graduation, post-graduation, PhD and diploma programmes. It is also affiliated with Kaloji Narayana Rao University of Health Sciences and the Andhra Pradesh Para Medical Board. During 2022, Sunshine Hospitals became subsidiary of the Company effective from April, 2022. In 2022-23, the Company opened an exclusive Gastroenterology unit at Vizag. During FY 2022-23, Sarvejana Healthcare Private Limited became a Subsidiary of the Company effective 01st April 2022; SPANV Medisearch Lifesciences Private Limited became the Subsidiary of Company on 01.09.2022. Suryateja Healthcare Private Limited has ceased to be step down subsidiary of the Company w.e.f. December 01, 2022.

Registered Address

D No 1-8-31/1 Minister`s Road, , Secunderabad, Telangana, 500003

Tel : 91-40-4418 6000
Email : cs:kimshospitals.com
Website : http://www.kimshospitals.com

Link Intime India Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 543308
Book Closure Date (Month) :
BSE Group : A
ISIN : INE967H01017

FAQ’s on Krishna Institute of Medical Sciences Ltd Shares

You can buy Krishna Institute of Medical Sciences Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Krishna Institute of Medical Sciences Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 24, 2024 03:59 PM the closing price of Krishna Institute of Medical Sciences Ltd was Rs.2,054.80.

The latest PE ratio of Krishna Institute of Medical Sciences Ltd as of Jun 24, 2024 03:59 PM is 53.02

The latest PB ratio of Krishna Institute of Medical Sciences Ltd as of Jun 24, 2024 03:59 PM is 0.11

The 52-week high of Krishna Institute of Medical Sciences Ltd share price is Rs. 2,356.40 while the 52-week low is Rs. 1,720.00

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 24, 2024 03:59 PM, the market cap of Krishna Institute of Medical Sciences Ltd stood at Rs. 16,444.15 Cr.

Download App

Download Our App

Play Store App Store
market app